Advertisements


Biotechs With No Drugs in Trial Are Raising Millions in IPOs

Biotech IPOs are on track for a near-record year, with a crop of offerings that are younger, more highly valued—and some say riskier—than any in recent memory......»»

Category: smallbizSource: wsjOct 31st, 2018

War against the superbugs: Mass. biotechs step up to fight antibiotic resistance

In a world where superbugs are overpowering various antibiotic drugs, threatening millions of lives, Massachusetts biotechs are fighting hard to ensure the bugs don't become the industry's kryptonite......»»

Category: topSource: bizjournalsOct 25th, 2018

WeWork CEO owns some buildings WeWork leases, raising conflict of interest concerns

WeWork CEO Adam Neumann is reportedly making money on properties he owns and leases back to the co-working giant. The Wall Street Journal cited unnamed sources on Wednesday who said that Neumann, an Israeli-born entrepreneur, has made millions of d.....»»

Category: topSource: bizjournalsJan 16th, 2019

Government Shutdown Stymies Opportunity-Zone Investors

The impasse is holding up scores of real-estate investors and developers who have been raising hundreds of millions of dollars to take advantage of what could be one of the most attractive tax breaks in years......»»

Category: smallbizSource: wsjJan 16th, 2019

GE CEO Larry Culp Could Get Millions of Shares — if He Can Double the Stock Price

The beleaguered conglomerate will award Culp with shares for raising the stock price above $18.60, and bigger bonuses for higher prices......»»

Category: topSource: barronsJan 5th, 2019

GE CEO Larry Culp Could Get Millions of Shares --- if He Can Double the Stock Price

The beleaguered conglomerate will award Culp with shares for raising the stock price above $18.60, and bigger bonuses for higher prices......»»

Category: topSource: barronsJan 5th, 2019

Drugmakers Celebrate the New Year by Raising Prices on Hundreds of Drugs an Average of 6.3%

The average price increase is nearly three times the current U.S. inflation rate. Three dozen drugmakers are raising prices on more than 250 prescription drugs, according to an analysis by RX Savings .....»»

Category: europeSource: fortuneJan 2nd, 2019

Drugmakers Raise Prices on Hundreds of Medicines

Pharmaceutical companies are raising prices on hundreds of drugs, with Allergan setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis......»»

Category: asiaSource: wsjJan 2nd, 2019

The Wall Street Journal: Dozens of pharmaceutical makers raise prices on hundreds of drugs to ring in the new year

Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan PLC setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis......»»

Category: topSource: marketwatchJan 1st, 2019

Report finds growing pains for rare disease drugs, but local biotechs buck trend

For the second year in a row, Waltham-based consulting firm Trinity Partners found that orphan and ultra-orphan treatments stumbled out of the gate and have failed to find their footing after three years of sales. But some local biotechs bucked the trend......»»

Category: topSource: bizjournalsDec 17th, 2018

Top 10 Healthcare Stories of 2018

New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018......»»

Category: topSource: foxnewsDec 13th, 2018

Flywheel alumni raising millions to take tech platform to boutique fitness studios

D.C.-based Mariana Tek licenses its technology to boutique fitness studios......»»

Category: topSource: bizjournalsDec 12th, 2018

How a new OHSU Knight Cancer program could eliminate trial and error in drug treatments

A new OHSU Knight Cancer program uses detailed data gathering to determine the most effective drugs for treating tumors.....»»

Category: topSource: bizjournalsNov 19th, 2018

Pfizer to Raise Prices on 41 Drugs

Pfizer plans to resume its practice of raising drug prices early next year after bowing to pressure from President Trump over the summer when the company rolled back some increases......»»

Category: asiaSource: wsjNov 17th, 2018

Months After Trump Scolded Pfizer About Raising Drug Prices, It’s Raising Prices on 41 Drugs, Report Says

"They are merely taking advantage of the poor & others unable to defend themselves," the president tweeted. In July, Pfizer backtracked on its plans to r.....»»

Category: europeSource: fortuneNov 16th, 2018

Australia’s CSIRO, CommBank Complete ‘Smart Money’ Blockchain Trial

Australia's federal science agency CSIRO and CommBank have trialed a blockchain payments prototype they say could save "hundreds of millions" a year......»»

Category: forexSource: coindeskNov 13th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»

Category: earningsSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»

Category: blogSource: benzingaNov 4th, 2018

Five things you need to know today, and why you don"t want to win the Mega Millions

Good morning, Boston. Here are five things you need to know to help start your busy day. Harvard affirmative action trial, continued A former Harvard Crimson reporter who now writes for Politico, Josh Gerstein explores not only the current trial alle.....»»

Category: topSource: bizjournalsOct 22nd, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzingaOct 21st, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks.....»»

Category: blogSource: benzingaOct 21st, 2018